%0 Journal Article
%T Adjuvant antiviral therapy for the prevention of hepatocellular carcinoma recurrence after liver resection: indicated for all patients with chronic hepatitis B?
%A Akateh, Clifford
%A Pawlik, Timothy M.
%A Cloyd, Jordan M.
%J Annals of Translational Medicine
%D 2018
%B 2018
%9 
%! Adjuvant antiviral therapy for the prevention of hepatocellular carcinoma recurrence after liver resection: indicated for all patients with chronic hepatitis B?
%K 
%X Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide with an increasing incidence that affects all major demographic groups (1,2). Hepatitis B virus (HBV) infection is a major risk factor and leading cause of HCC development, accounting for approximately 33% of HCC cases worldwide (and up to 2/3 of cases in under-developed countries) (3,4).
%U https://atm.amegroups.org/article/view/20836
%V 6
%N 20
%P 397
%@ 2305-5847